PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
21.72
+0.81 (3.87%)
At close: Jun 18, 2026, 4:00 PM EDT
21.82
+0.10 (0.46%)
After-hours: Jun 18, 2026, 7:48 PM EDT
PROCEPT BioRobotics Employees
PROCEPT BioRobotics had 888 employees as of December 31, 2025. The number of employees increased by 132 or 17.46% compared to the previous year.
Employees
888
Change (1Y)
132
Growth (1Y)
17.46%
Revenue / Employee
$362,640
Profits / Employee
-$115,398
Market Cap
1.24B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 888 | 132 | 17.46% |
| Dec 31, 2024 | 756 | 130 | 20.77% |
| Dec 31, 2023 | 626 | 198 | 46.26% |
| Dec 31, 2022 | 428 | 194 | 82.91% |
| Dec 31, 2021 | 234 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,900 |
| Enovis | 7,802 |
| QuidelOrtho | 6,500 |
| Integra LifeSciences Holdings | 4,427 |
| CONMED | 3,900 |
| Tandem Diabetes Care | 2,500 |
| Avanos Medical | 2,287 |
| Artivion | 1,800 |
PRCT News
- 8 days ago - Leerink downgrades Procept BioRobotics to Market Perform, lowers target to $29 - TheFly
- 8 days ago - Procept BioRobotics downgraded to Market Perform from Outperform at Leerink - TheFly
- 17 days ago - PROCEPT BioRobotics Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 22 days ago - PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval - GlobeNewsWire
- 5 weeks ago - AUA Guidelines Strengthen Recommendation for Aquablation® Therapy - GlobeNewsWire
- 5 weeks ago - PROCEPT BioRobotics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June - GlobeNewsWire
- 7 weeks ago - Procept BioRobotics price target raised to $35 from $28 at Piper Sandler - TheFly